PRESS RELEASE For immediate release Devonian Health Group Announces the Closing of $1,805,000 Non-Brokered Financing. QUÉBEC CITY, May 4, 2020 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD), a clinical stage botanical pharmaceutical...
Press Releases
Devonian Health Group Announces an Increase to its Non-Brokered Financing to $2,000,000
PRESS RELEASE For immediate release Devonian Health Group Announces an Increase to its Non-Brokered Financing to $2,000,000. QUÉBEC CITY, April 24, 2020 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD), a clinical stage botanical...
Devonian Health Group Announces the Issuance of Securities in Interest Settlement Due to Debenture Holders, a $330,000 Non-Brokered Financing and the Grant of Options
PRESS RELEASE For immediate release Devonian Health Group Announces the Issuance of Securities in Interest Settlement Due to Debenture Holders, a $330,000 Non-Brokered Financing and the Grant of Options. QUÉBEC CITY, April 22, 2020 – Devonian Health Group Inc....
Devonian Health Group Announces R-Spinasome® anti-aging technology global sales and marketing partnership
PRESS RELEASE For immediate release Devonian Health Group Announces R-Spinasome® anti-aging technology global sales and marketing partnership. QUEBEC, February 11, 2020 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage...
Devonian issues settlements of interest due to a debenture holder and announces the results of the annual general meeting of shareholders
PRESS RELEASE For immediate release DEVONIAN ISSUES SETTLEMENTS OF INTEREST DUE TO A DEBENTURE HOLDER AND ANNOUNCES THE RESULTS OF THE ANNUAL GENERAL MEETING OF SHAREHOLDERS. QUEBEC, – January 29, 2020 Devonian Health Group Inc. (“Devonian” or the...
Devonian Health Group Announces presentation to the World Conference on Ageing and Gerontology and a correction on expiry date of warrants
PRESS RELEASE For immediate release Devonian Health Group Announces presentation to the World Conference on Ageing and Gerontology and a correction on expiry date of warrants. QUEBEC, January 23, 2020 – Devonian Health Group Inc. (“Devonian” or the...
Devonian Health Group Announces Cannabis Cutting-Edge Extraction Equipment in its Montmagny Facility
PRESS RELEASE For immediate release Devonian Health Group Announces Cannabis Cutting-Edge Extraction Equipment in its Montmagny Facility. QUEBEC, January 15, 2020 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage...
Devonian Health Group Obtains Cannabis Research License from Health Canada
PRESS RELEASE For immediate release DEVONIAN HEALTH GROUP OBTAINS CANNABIS RESEARCH LICENSE FROM HEALTH CANADA. QUEBEC, October 3, 2019 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical...
Devonian Health Group Announces the Formation of a Clinical Dermatology Advisory Board with mandate to assist in the development of Cannabinoids-based pharmaceutical products
PRESS RELEASE For immediate release Devonian Health Group Announces the Formation of a Clinical Dermatology Advisory Board with mandate to assist in the development of Cannabinoids-based pharmaceutical products. QUEBEC, September 4, 2019 – Devonian Health Group...
Devonian Health Group announces the publication of positive results of the Purgenesis® Anti-aging Care clinical study in the Journal of Cosmetic Dermatology
PRESS RELEASE For immediate release Devonian Health Group announces the publication of positive results of the Purgenesis® Anti-aging Care clinical study in the Journal of Cosmetic Dermatology. QUEBEC, August 28, 2019 – Devonian Health Group Inc. (“Devonian” or...